Literature DB >> 21723310

Crotoxin and phospholipases A₂ from Crotalus durissus terrificus showed antiviral activity against dengue and yellow fever viruses.

Vanessa Danielle Menjon Muller1, Raquel Rinaldi Russo, Adelia Cristina Oliveira Cintra, Marco Aurélio Sartim, Raquel De Melo Alves-Paiva, Luiz Tadeu Moraes Figueiredo, Suely Vilela Sampaio, Victor Hugo Aquino.   

Abstract

Dengue is the most important arbovirus in the world with an estimated of 50 million dengue infections occurring annually and approximately 2.5 billion people living in dengue endemic countries. Yellow fever is a viral hemorrhagic fever with high mortality that is transmitted by mosquitoes. Effective vaccines against yellow fever have been available for almost 70 years and are responsible for a significant reduction of occurrences of the disease worldwide; however, approximately 200,000 cases of yellow fever still occur annually, principally in Africa. Therefore, it is a public health priority to develop antiviral agents for treatment of these virus infections. Crotalus durissus terrificus snake, a South American rattlesnake, presents venom with several biologically actives molecules. In this study, we evaluated the antiviral activity of crude venom and isolated toxins from Crotalus durissus terrificus and found that phospholipases A₂ showed a high inhibition of Yellow fever and dengue viruses in VERO E6 cells. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723310     DOI: 10.1016/j.toxicon.2011.05.021

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  27 in total

Review 1.  Experimental therapies for yellow fever.

Authors:  Justin G Julander
Journal:  Antiviral Res       Date:  2012-12-10       Impact factor: 5.970

Review 2.  Antitumoral activity of snake venom proteins: new trends in cancer therapy.

Authors:  Leonardo A Calderon; Juliana C Sobrinho; Kayena D Zaqueo; Andrea A de Moura; Amy N Grabner; Maurício V Mazzi; Silvana Marcussi; Auro Nomizo; Carla F C Fernandes; Juliana P Zuliani; Bruna M A Carvalho; Saulo L da Silva; Rodrigo G Stábeli; Andreimar M Soares
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

3.  Phospholipase A2 isolated from the venom of Crotalus durissus terrificus inactivates dengue virus and other enveloped viruses by disrupting the viral envelope.

Authors:  Vanessa Danielle Muller; Ricardo Oliveira Soares; Nilton Nascimento dos Santos; Amanda Cristina Trabuco; Adelia Cristina Cintra; Luiz Tadeu Figueiredo; Antonio Caliri; Suely Vilela Sampaio; Victor Hugo Aquino
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

4.  Galectin-1 exerts inhibitory effects during DENV-1 infection.

Authors:  Karina Alves Toledo; Marise Lopes Fermino; Camillo Del Cistia Andrade; Thalita Bachelli Riul; Renata Tomé Alves; Vanessa Danielle Menjon Muller; Raquel Rinaldi Russo; Sean R Stowell; Richard D Cummings; Victor Hugo Aquino; Marcelo Dias-Baruffi
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

Review 5.  Antiviral activity of animal venom peptides and related compounds.

Authors:  Élida Cleyse Gomes da Mata; Caroline Barbosa Farias Mourão; Marisa Rangel; Elisabeth Ferroni Schwartz
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-01-06

6.  Broad-spectrum antiviral agents: secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane.

Authors:  Ming Chen; Chie Aoki-Utsubo; Masanori Kameoka; Lin Deng; Yutaka Terada; Wataru Kamitani; Kei Sato; Yoshio Koyanagi; Makoto Hijikata; Keiko Shindo; Takeshi Noda; Michinori Kohara; Hak Hotta
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

7.  Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle.

Authors:  Jacqueline Farinha Shimizu; Carina Machado Pereira; Cintia Bittar; Mariana Nogueira Batista; Guilherme Rodrigues Fernandes Campos; Suely da Silva; Adélia Cristina Oliveira Cintra; Carsten Zothner; Mark Harris; Suely Vilela Sampaio; Victor Hugo Aquino; Paula Rahal; Ana Carolina Gomes Jardim
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

8.  Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model.

Authors:  Veridiana Ester Barros; Nilton Nascimento dos Santos-Junior; Alberto Anastacio Amarilla; Adriana Moreira Soares; Rafael Lourencini; Amanda Cristina Trabuco; Victor Hugo Aquino
Journal:  BMC Microbiol       Date:  2015-09-29       Impact factor: 3.605

9.  Molecular characterization of Lys49 and Asp49 phospholipases A₂from snake venom and their antiviral activities against Dengue virus.

Authors:  Alzira B Cecilio; Sergio Caldas; Raiana A De Oliveira; Arthur S B Santos; Michael Richardson; Gustavo B Naumann; Francisco S Schneider; Valeria G Alvarenga; Maria I Estevão-Costa; Andre L Fuly; Johannes A Eble; Eladio F Sanchez
Journal:  Toxins (Basel)       Date:  2013-10-15       Impact factor: 4.546

10.  The Effect of Hydrocotyle sibthorpioides Lam. Extracts on In Vitro Dengue Replication.

Authors:  Fitrien Husin; Yean Yean Chan; Siew Hua Gan; Siti Amrah Sulaiman; Rafidah Hanim Shueb
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.